@article {1485,
	title = {Blood-bank testing for infectious diseases: how safe is blood transfusion?},
	journal = {Trends Mol Med},
	volume = {8},
	year = {2002},
	note = {Strong, D Michael Katz, Louis England Trends in molecular medicine Trends Mol Med. 2002 Jul;8(7):355-8.},
	month = {Jul},
	pages = {355 - 8},
	edition = {37450},
	abstract = {Remarkable progress has been made in transfusion safety from infection over the past three decades. Donor deferrals for at-risk behaviors, the introduction of more-sensitive viral-screening assays and the recent introduction of nucleic-acid amplification technology have nearly eliminated transmission of HIV and hepatitis C virus (HCV) by blood transfusion in North America. Nevertheless, risks of other infectious agents for which such robust screening tools have not been developed, such as bacteria and parasites, still remain. As a result of these successes, the non-infectious risks such as misidentification of patients and inadequate and inappropriate transfusion have become the primary sources of transfusion risk.},
	keywords = {Blood Banks / *standards, Blood Transfusion / *adverse effects / standards, Enzyme-Linked Immunosorbent Assay, Hepatitis C / prevention \& control / transmission, HIV Infections / prevention \& control / transmission, Humans, Laboratories, Hospital / *standards},
	issn = {1471-4914 (Print) 1471-4914 (Linking)},
	doi = {S1471491402023614 [pii]},
	author = {Strong,D. M. and Katz,L.}
}
